Understanding And Treating Triple-Negative Breast Cancer

News — By on January 9, 2009 at 7:57 am

Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile, aggressive behavior, distinct patterns of metastasis, and lack of targeted therapies. Although not synonymous, the majority of triple-negative breast cancers carry the “basal-like” molecular profile on gene expression arrays.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback